AN2 Therapeutics Return on Net Operating Assets Trends

AN2 Therapeutics, Inc. (ANTX)

4.94 -0.50 (-9.19%) USD | NASDAQ | Mar 13, 16:00

4.95 +0.01 (+0.20%) After-Hours: 20:00

View Return on Net Operating Assets for ANTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

Relmada Therapeutics, Inc.	Upgrade
ACADIA Pharmaceuticals, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Savara, Inc.	Upgrade
BioMarin Pharmaceutical, Inc.	Upgrade